These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 28831739

  • 1. Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.
    Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP.
    Ann Nucl Med; 2017 Nov; 31(9):696-702. PubMed ID: 28831739
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study.
    Harsini S, Saprunoff H, Alden T, Mohammadi B, Wilson D, Bénard F.
    J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167
    [Abstract] [Full Text] [Related]

  • 4. Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.
    Endepols H, Morgenroth A, Zlatopolskiy BD, Krapf P, Zischler J, Richarz R, Muñoz Vásquez S, Neumaier B, Mottaghy FM.
    BMC Cancer; 2019 Jun 26; 19(1):633. PubMed ID: 31242896
    [Abstract] [Full Text] [Related]

  • 5. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
    Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, Cho SY, Pomper MG, Allaf ME.
    Ann Nucl Med; 2015 Dec 26; 29(10):877-82. PubMed ID: 26286635
    [Abstract] [Full Text] [Related]

  • 6. Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP, Li X, Trock BJ, Werner RA, Frey S, DiGianvittorio M, Bleiler JK, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG.
    J Nucl Med; 2020 Feb 26; 61(2):183-188. PubMed ID: 31451492
    [Abstract] [Full Text] [Related]

  • 7. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.
    Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP.
    Mol Imaging Biol; 2020 Feb 26; 22(1):190-197. PubMed ID: 31140110
    [Abstract] [Full Text] [Related]

  • 8. Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.
    Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG.
    J Nucl Med; 2017 Jun 26; 58(6):942-946. PubMed ID: 27932557
    [Abstract] [Full Text] [Related]

  • 9. Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT.
    Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA.
    Mol Imaging Biol; 2019 Jun 26; 21(3):567-573. PubMed ID: 30218388
    [Abstract] [Full Text] [Related]

  • 10. Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT.
    Meyer AR, Carducci MA, Denmeade SR, Markowski MC, Pomper MG, Pierorazio PM, Allaf ME, Rowe SP, Gorin MA.
    Ann Nucl Med; 2019 Aug 26; 33(8):617-623. PubMed ID: 31147927
    [Abstract] [Full Text] [Related]

  • 11. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.
    Sahakyan K, Li X, Lodge MA, Werner RA, Bundschuh RA, Bundschuh L, Kulkarni HR, Schuchardt C, Baum RP, Pienta KJ, Pomper MG, Ross AE, Gorin MA, Rowe SP.
    Mol Imaging Biol; 2020 Feb 26; 22(1):181-189. PubMed ID: 31115751
    [Abstract] [Full Text] [Related]

  • 12. 18F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.
    Osman MM, Iravani A, Mitchell C, Hicks RJ, Perry E, Hofman MS.
    J Nucl Med; 2024 Sep 03; 65(9):1383-1386. PubMed ID: 39089815
    [Abstract] [Full Text] [Related]

  • 13. Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.
    Szabo Z, Mena E, Rowe SP, Plyku D, Nidal R, Eisenberger MA, Antonarakis ES, Fan H, Dannals RF, Chen Y, Mease RC, Vranesic M, Bhatnagar A, Sgouros G, Cho SY, Pomper MG.
    Mol Imaging Biol; 2015 Aug 03; 17(4):565-74. PubMed ID: 25896814
    [Abstract] [Full Text] [Related]

  • 14. Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer.
    Jansen BHE, Yaqub M, Voortman J, Cysouw MCF, Windhorst AD, Schuit RC, Kramer GM, van den Eertwegh AJM, Schwarte LA, Hendrikse NH, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.
    J Nucl Med; 2019 Dec 03; 60(12):1730-1735. PubMed ID: 31000583
    [Abstract] [Full Text] [Related]

  • 15. Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
    Yin Y, Werner RA, Higuchi T, Lapa C, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.
    J Nucl Med; 2019 Apr 03; 60(4):511-516. PubMed ID: 30190303
    [Abstract] [Full Text] [Related]

  • 16. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP, Macura KJ, Mena E, Blackford AL, Nadal R, Antonarakis ES, Eisenberger M, Carducci M, Fan H, Dannals RF, Chen Y, Mease RC, Szabo Z, Pomper MG, Cho SY.
    Mol Imaging Biol; 2016 Jun 03; 18(3):411-9. PubMed ID: 27080322
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.
    Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.
    J Nucl Med; 2019 Aug 03; 60(8):1111-1117. PubMed ID: 30630941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.